Crystapharm SRL
The score of Crystapharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1 % Total assets +248 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Crystapharm's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 19 Sep 2025
- Year ended 30 Jun 2024filed on 09 Oct 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 17 Oct 2022
- Year ended 31 Dec 2020filed on 14 Aug 2021
Crystapharm's financial analysis
- Solvency27.0%sector median: 56.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Crystapharm
Crystapharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0475.358.495
- VAT number
- BE0475358495
- Peppol
- Registered · 0208:0475358495 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jul 2001
- Registered office
- 8790 Waregem
- Latest accounts
- 2025 · filed on 19 Sep 2025
- Activity
- Activities of certified accountants (tax experts) (NACE 69201)
Crystapharm (SRL) has been based in Waregem since 2001, active in: activities of certified accountants (tax experts). For 2025, it reports a net profit of 635,309 € and equity of €1.28m; its revenue is not published. Its solvency stands at 27.0%, below the median of its sector (56.7%).
Companies similar to Crystapharm
Companies in the same business, of comparable size and area, outside its group.
- Odegas Accounting, bookkeeping and auditing activities; tax consultancy Wortegem-Petegem · balance sheet €4.71m
- P & A Consulting Accounting, bookkeeping and auditing activities; tax consultancy Wielsbeke · balance sheet €4.61m
- WB Consult Accounting, bookkeeping and auditing activities; tax consultancy Ingelmunster · balance sheet €4.13m
- Ignace Taelman Accounting, bookkeeping and auditing activities; tax consultancy Avelgem · balance sheet €6.10m
- Vincent Trevisan Accounting, bookkeeping and auditing activities; tax consultancy Chaudfontaine · balance sheet €3.17m
- Ghesquière Accounting, bookkeeping and auditing activities; tax consultancy Kortrijk · balance sheet €4.83m
- XPR TAX Accounting, bookkeeping and auditing activities; tax consultancy Brussels · balance sheet €4.84m
- MA Holding Accounting, bookkeeping and auditing activities; tax consultancy Wetteren · balance sheet €4.88m
Frequently asked questions about Crystapharm
What is the revenue of Crystapharm?
Crystapharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Crystapharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0475358495 for Crystapharm, if the company is VAT-registered. Its company number (CBE) is 0475.358.495.
Where is the registered office of Crystapharm?
According to the CBE register, the registered office of Crystapharm is in 8790 Waregem.
What is the equity of Crystapharm?
At the close of the 2025 financial year, the equity of Crystapharm amounts to 1,280,673 €, a solvency of 27.0% of total assets.
Who manages Crystapharm?
The register lists 8 active mandates at Crystapharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Crystapharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →